Frazier Management LLC
- SEC CIK
- 0001032165
- 最新申報
- 2022/11/14
2021 年第 1 季持倉
持倉截至 2021/3/31，2021/5/12 申報。只含多頭部位。
- 持股檔數
- 35
- 2020 年第 4 季沒有 13F 資料
- 總值
- $12.5 億
- 2020 年第 4 季沒有 13F 資料
Livermore 的 13F 資料從 2021 年第 1 季開始，這一季沒有前一季可以比較，所以不顯示股數變化與動作。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ARQTArcutis Biotherapeutics, Inc. | COM | 10,542,790 | $3.05 億 | 24.5% | – | – | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 5,827,415 | $2.19 億 | 17.6% | – | – | 歷史 |
| PASGPassage BIO, Inc. | COM | 5,009,219 | $8,756 萬 | 7.0% | – | – | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 3,566,912 | $7,070 萬 | 5.7% | – | – | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 895,000 | $6,895 萬 | 5.5% | – | – | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,917,157 | $6,179 萬 | 5.0% | – | – | 歷史 |
| PCVXVaxcyte, Inc. | COM | 2,309,554 | $4,561 萬 | 3.7% | – | – | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,312,999 | $4,157 萬 | 3.3% | – | – | 歷史 |
| Translate Bio, Inc.89374L104 | COM | 2,182,789 | $3,599 萬 | 2.9% | – | – | – |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 3,123,107 | $3,342 萬 | 2.7% | – | – | – |
| SNDXSyndax Pharmaceuticals Inc | COM | 1,435,045 | $3,209 萬 | 2.6% | – | – | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 2,571,450 | $2,726 萬 | 2.2% | – | – | 歷史 |
| STROSutro Biopharma, Inc. | COM | 1,001,421 | $2,279 萬 | 1.8% | – | – | 歷史 |
| ANABAnaptysbio, Inc | COM | 899,700 | $1,939 萬 | 1.6% | – | – | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 696,000 | $1,754 萬 | 1.4% | – | – | 歷史 |
| MTEMMolecular Templates, Inc. | COM | 1,374,047 | $1,734 萬 | 1.4% | – | – | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 2,544,500 | $1,573 萬 | 1.3% | – | – | 歷史 |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 1,501,000 | $1,525 萬 | 1.2% | – | – | – |
| ADVMAdverum Biotechnologies, Inc. | COM | 1,437,028 | $1,417 萬 | 1.1% | – | – | 歷史 |
| RGNXREGENXBIO Inc. | COM | 351,954 | $1,201 萬 | 1.0% | – | – | 歷史 |
| GRTSGritstone bio, Inc. | COM | 1,030,878 | $972.1 萬 | 0.8% | – | – | 歷史 |
| APTXAptinyx Inc. | COM | 3,190,079 | $957.0 萬 | 0.8% | – | – | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 316,616 | $919.8 萬 | 0.7% | – | – | 歷史 |
| IMVTImmunovant, Inc. | COM | 508,000 | $814.8 萬 | 0.7% | – | – | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 156,000 | $790.3 萬 | 0.6% | – | – | 歷史 |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 550,000 | $676.5 萬 | 0.5% | – | – | – |
| EPZMEpizyme, Inc. | COM | 739,369 | $644.0 萬 | 0.5% | – | – | 歷史 |
| AVDLAvadel Pharmaceuticals PLC | SPONSORED ADR | 578,104 | $522.6 萬 | 0.4% | – | – | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 1,296,743 | $494.8 萬 | 0.4% | – | – | – |
| ALNAAllena Pharmaceuticals, Inc. | COM | 3,330,373 | $462.9 萬 | 0.4% | – | – | 歷史 |
| SRRASierra Oncology, Inc. | COM NEW | 202,803 | $349.4 萬 | 0.3% | – | – | 歷史 |
| CRDFCardiff Oncology, Inc. | COM | 293,500 | $271.8 萬 | 0.2% | – | – | 歷史 |
| ITRMIterum Therapeutics plc | SHS | 1,538,316 | $216.9 萬 | 0.2% | – | – | 歷史 |
| GRTXGalera Therapeutics, Inc. | COM | 241,000 | $212.6 萬 | 0.2% | – | – | 歷史 |
| Nabriva Therapeutics plcG63637113 | SHS | 425,650 | $70.7 萬 | 0.1% | – | – | – |